MAP2K1 and lymphopenia: Similarly, lymphocytosis was more common in the MAP2K1 cohort (16.7%) compared to BRAF (3.1%), while lymphopenia was higher in BRAF-mutated patients (25.0%) than in MAP2K1-mutated patients (8.3%).